Showing results (51-60 of 232) with videos related to
Sort By:
Pageof 24
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1974
Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneityP K Thomas, D B CalneClinical Neuropharmacology|January 1, 1986
Bromocriptine: long-term low-dose therapy in Parkinson's diseaseP F Teychenne, D Bergsrud, R L Elton, et al.Neurology|June 1, 1976
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonismR Kartzinel, I Shoulson, D B CalneNihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|May 25, 1989
[Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia]J Okada, R Peppard, D B CalneJournal of Neurology, Neurosurgery, and Psychiatry|February 1, 1979
Vocal cord paralysis in the Shy-Drager syndromeA Williams, D Hanson, D B CalneJournal of Neural Transmission|January 1, 1981
Recent advances in the treatment of Parkinson's disease: the role of bromocriptineP A Le Witt, D B CalneNeurology|August 1, 1976
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonismR Kartzinel, I Shoulson, D B CalneAnnals of Neurology|December 1, 1992
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomaticM Schulzer, E Mak, D B CalneThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1988
Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapyT A Hurwitz, D B Calne, K WatermanAnnals of Neurology|January 1, 1992
Criteria for diagnosing Parkinson's diseaseD B Calne, B J Snow, C LeePageof 24